Cargando…
Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy
Pancreatic ductal adenocarcinoma (PDA), the most frequent type of pancreatic cancer, remains one of the most challenging problems for the biomedical and clinical fields, with abysmal survival rates and poor therapy efficiency. Desmoplasia, which is abundant in PDA, can be blamed for much of the mech...
Autores principales: | Martinez-Bosch, Neus, Vinaixa, Judith, Navarro, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789356/ https://www.ncbi.nlm.nih.gov/pubmed/29301364 http://dx.doi.org/10.3390/cancers10010006 |
Ejemplares similares
-
The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer
por: Martínez-Bosch, Neus, et al.
Publicado: (2016) -
The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer
por: Manero-Rupérez, Noemí, et al.
Publicado: (2020) -
Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion
por: Gan, Li-Lian, et al.
Publicado: (2020) -
Mechanism of immune evasion in breast cancer
por: Wang, Mozhi, et al.
Publicado: (2017) -
Mechanisms of immune evasion in bladder cancer
por: Crispen, Paul L., et al.
Publicado: (2019)